This is a routine, small-scale sale by a major institutional affiliate. No material price impact expected. Monitor for any subsequent larger sales or changes in OrbiMed's 13F position for broader sentiment shifts.
Price Chart
Executive Summary
OrbiMed Advisors LLC, on behalf of OrbiMed Genesis Master Fund, filed a Form 144 notice of intent to sell 9,086 shares of Enliven Therapeutics (ELVN) common stock, valued at approximately $385,000. The shares were acquired via merger in 2023, and the sale is planned for open-market execution through Themis Trading. The small size relative to ELVN's $2.8B market cap and OrbiMed's likely holdings makes this a routine portfolio adjustment with no material signal.
Key Facts
- OrbiMed Advisors LLC (on behalf of OrbiMed Genesis Master Fund) filed Form 144 to sell 9,086 shares of ELVN common stock.
- Estimated sale value: $384,882.96 (based on filing data).
- Shares were originally acquired on February 23, 2023 via merger (from IMARA Inc.).
- Sale is to be executed on Nasdaq through Themis Trading LLC.
- Filing date: June 15, 2026.
Financial Impact
Sale of ~$385K in ELVN stock, representing ~0.014% of market cap — negligible impact.
Risk Factors
- None material from this filing; the sale may not even execute as Form 144 is only an intent.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0000947871-26-000627 |
| Document: 0000947871-26-000627-index.html | 0000947871-26-000627 |
| Document: 0000947871-26-000627.txt | 0000947871-26-000627 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | SC 13G/A | $41.80 | awaiting T+5 | — | $43.69 (+4.52%) |
Oct 21, 2026 6d ago | Insider Cluster | $41.93 | awaiting T+5 | — | $43.69 (+4.20%) |
Oct 19, 2026 8d ago | 144 | $41.25 $43.69 | ▲ +5.92% | ▲ +5.84% | $43.69 (+5.92%) |
Oct 16, 2026 11d ago | 3 | $38.70 $41.49 | ▲ +7.21% | ▲ +7.35% | $43.69 (+12.89%) |
Oct 14, 2026 13d ago | 8-K | $39.33 $41.93 | ▲ +6.61% | ▲ +7.63% | $43.69 (+11.09%) |
Sep 21, 2026 5w ago | Insider Cluster | $48.19 $46.51 | ▼ −3.49% | ▼ −2.30% | $43.69 (−9.34%) |
Sep 4, 2026 7w ago | 144 | $59.32 $54.43 | ▼ −8.24% | ▼ −7.03% | $43.69 (−26.35%) |
Aug 19, 2026 9w ago | Insider Cluster | $58.97 $60.50 | ▲ +2.59% | ▲ +1.48% | $43.69 (−25.91%) |
Aug 9, 2026 11w ago | Institutional Cluster | $59.42 $59.54 | ▲ +0.19% | ▲ +0.24% | $43.69 (−26.47%) |
Jul 21, 2026 14w ago | Insider Cluster | $52.85 $52.97 | ▲ +0.23% | ▲ +2.63% | $43.69 (−17.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers